Health
EU regulator probes possible kidney damage from coronavirus drug – Macau Business
The EU’s medicines regulator said Friday it is investigating reports of possible “acute” kidney damage in patients taking the coronavirus drug remdesivir
The EU’s medicines regulator said Friday it is investigating reports of possible “acute” kidney damage in patients taking the coronavirus drug remdesivir, made by US pharma giant Gilead.
The European Medicines Agency recommended the use of the anti-viral drug, sold under the brand name Veklury, in June after studies showed it could reduce the length of hospital stays for Covid-19 sufferers.
“EMA’s safety committee has started a review… to assess reports of acute kidney injury in some patients …
-
General24 hours agoCampers evacuated, residents on alert as Moreton Island bushfire intensifies
-
General21 hours agoHundreds attend justice march for Kaiden Morgan-Johnston in Morwell
-
Noosa News22 hours agoAlleged Gold Coast conman exposed: elderly woman’s life savings vanish in shocking scam
-
Noosa News22 hours agoHow Roosters star Eliza Lopamaua found her way to NRLW